Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Microscopes News

12/13/2024
BreakingDealsDiagnosticDigitalFundusMicroscopes
Topcon Weighing Takeover Bids from Private Equity Firms, Bloomberg Reports
Topcon Weighing Takeover Bids from Private Equity Firms, Bloomberg Reports

Topcon is considering takeover bids from suitors, including the private equity firms KKR & Co. and EQT AB, according to a report Dec. 10 from financial news outlet Bloomberg. The Tokyo-based ophtha...

11/14/2024
DiagnosticMicroscopesNewsletterSurgical
Haag-Streit’s Metis Poised to Join Innovation-Rich and Growing Advanced Microscopes Segment
Haag-Streit’s Metis Poised to Join Innovation-Rich and Growing Advanced Microscopes Segment

Haag-Streit revealed its new Metis microscope at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting and showcased it again at the 2024 AAO meeting. The Metis is specifica...

11/14/2024
CataractClinical TrialDealsDiagnosticDry EyeFundingGene TherapyGlaucomaIndustryInstrumentsMicroscopesNewsletterOCTPresbyopiaRegulationRetinaStudySurgical
November 2024 Ophthalmic News Briefs
November 2024 Ophthalmic News Briefs

Heidelberg Engineering announced Oct. 14 that the US FDA had granted 510(k) clearance to its Flex Module for the Spectralis diagnostic imaging platform. The Flex Module mounts the Spectralis to a m...

10/11/2024
BreakingDiagnosticMicroscopes
Beyeonics One Introduces ‘Invisible Light’ Infrared Illumination
Beyeonics One Introduces ‘Invisible Light’ Infrared Illumination

Israel’s Beyeonics Vision announced Oct. 8 that it had incorporated “invisible light” technology, based on infrared night vision, into the Beyeonics One surgical visualization system. Beyeonics sai...

6/24/2024
DiagnosticEmergingMicroscopesNewsletterPharmaSurgicalTelehealth
Emerging Companies Pursuing Ophthalmic Indications, June 2024
Emerging Companies Pursuing Ophthalmic Indications, June 2024

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

5/22/2024
CataractChinaCornealDiagnosticDry EyeGlaucomaIndiaMicroscopesNewsletterPharmaRegulationRetina
May 2024 Ophthalmic News Briefs
May 2024 Ophthalmic News Briefs

Taiwan-based Formosa Pharmaceuticals announced May 9 that it had entered into an exclusive licensing agreement with Tabuk Pharmaceuticals to market clobetasol propionate 0.05% eye drops for post-su...

5/17/2024
BreakingMicroscopesSurgical
First Beyeonics One Ophthalmic Exoscope Installed at ASC in Florida
First Beyeonics One Ophthalmic Exoscope Installed at ASC in Florida

Israel’s Beyeonics Vision reported May 10 the first commercial installation of a Beyeonics One digital ophthalmic exoscope at Largo Ambulatory Surgery Center & Eye Institute in Largo, Florida. The ...

4/24/2024
ASCRSDiagnosticDigitalMicroscopesNewsletter
Digital Solutions are Underlying Theme at 2024 ASCRS Meeting
Digital Solutions are Underlying Theme at 2024 ASCRS Meeting

The ASCRS conference was a hub of diagnostic innovation and collaboration, despite the absence of a designated “Digital Day,” as provided at the 2023 meeting. Discussions on the integration of digi...

4/24/2024
Clinical TrialCornealData SecurityDealsDiagnosticDry EyeEnvironmentFundingGlaucomaIOLIndustryMicroscopesNewsletterRegulationRetina
April 2024 Ophthalmic News Briefs
April 2024 Ophthalmic News Briefs

Alexion, the rare disease unit of AstraZeneca, announced March 25 that the US FDA had approved its long-acting C5 complement inhibitor Ultomiris (ravulizumab-cwvz) for adults with neuromyelitis opt...

4/5/2024
BreakingDigitalIndustryMicroscopesSurgical
Beyeonics Vision Appoints A. Burton Tripathi, PhD, as CEO
Beyeonics Vision Appoints A. Burton Tripathi, PhD, as CEO

Israel’s Beyeonics Vision announced March 28 that it had appointed A. Burton Tripathi, PhD, as its new chief executive officer. Tripathi was formerly CEO of TrueVision 3D Surgical. After Alcon acqu...

10/24/2023
DiagnosticMicroscopesNewsletter
Scope Showdown: Three Strategics Compete for Technical Supremacy
Scope Showdown: Three Strategics Compete for Technical Supremacy

Three of the biggest names in ophthalmic equipment—Alcon, Carl Zeiss Meditec, and Bausch + Lomb—are funneling resources into digital technology, with a focus on streamlining the operating room and ...

10/24/2023
CataractClinical TrialDealsDiagnosticDry EyeGene TherapyGenericsIOLIndustryMicroscopesNewsletterOcular CancerRegulationRetina
October 2023 Ophthalmic News Briefs
October 2023 Ophthalmic News Briefs

Théa Pharma, the US subsidiary of France’s Laboratoires Théa, announced the launch Sept. 26 of once-daily Iyuzeh (latanoprost ophthalmic solution) 0.005% in the US market. Iyuzeh is the first prese...

10/13/2023
BreakingDiagnosticIndustryMicroscopes
Olaf Felske is Appointed CEO of Haag-Streit USA
Olaf Felske is Appointed CEO of Haag-Streit USA

Switzerland’s Haag-Streit Group announced Oct. 3 that it had appointed Olaf Felske as the new chief executive officer of Haag-Streit USA, its division based in Mason, Ohio. Haag-Streit USA distribu...

10/6/2023
BreakingDiagnosticDigitalIndustryMicroscopesSurgical
Joseph C. Papa Joins Beyeonics Surgical as Chairman of the Board
Joseph C. Papa Joins Beyeonics Surgical as Chairman of the Board

Israel’s Beyeonics announced Oct. 4 that ophthalmic industry veteran Joseph C. Papa had joined the company as chairman of the board of Beyeonics Surgical and board member of Beyeonics Vision. Papa ...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more